Stock ZYME ZYMEWORKS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zymeworks Inc.

Equities

ZYME

US98985Y1082

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
9.2 USD +2.22% Intraday chart for Zymeworks Inc. +11.38% -11.45%
05-02 Transcript : Zymeworks Inc., Q1 2024 Earnings Call, May 02, 2024
05-02 Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting
Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President
Zymeworks Inc. Announces the Composition of the Committees
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024
Zymeworks Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Zymeworks Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Zymeworks Inc. to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
Zymeworks Inc. Appoints Scott Platshon as Director
Zymeworks Announces Appointment of Dr. Alessandra Cesano to Its Board of Directors
Zymeworks Insider Sold Shares Worth $257,845, According to a Recent SEC Filing
Zymeworks Appoints Jeffrey Smith as Chief Medical Officer; Cash Runway Extended
Zymeworks Inc Announces Additional Leadership Appointments
Zymeworks Reports $50 Million Private Placement to EcoR1 Capital
Zymeworks Expects to Be Added to Nasdaq Biotech Index
Zymeworks Inc. Announces Changes to its Board
Zymeworks Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Zymeworks Inc Announces Resignation of Lota Zoth as Member of the Board of Directors
Zymeworks Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Zymeworks Inc. Announces Board Changes, Effective June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYME Stock
  4. News Zymeworks Inc.
  5. Other languages